Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to 0.36%.

  • Regenxbio's Return on Capital Employed rose 2000.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.56% for FY2024, which is 900.0% down from last year.
  • Per Regenxbio's latest filing, its Return on Capital Employed stood at 0.36% for Q3 2025, which was up 2000.0% from 0.4% recorded in Q2 2025.
  • Regenxbio's 5-year Return on Capital Employed high stood at 0.19% for Q4 2021, and its period low was 0.6% during Q4 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.38% (2023), whereas its average is 0.3%.
  • In the last 5 years, Regenxbio's Return on Capital Employed skyrocketed by 4300bps in 2022 and then tumbled by -6300bps in 2023.
  • Quarter analysis of 5 years shows Regenxbio's Return on Capital Employed stood at 0.19% in 2021, then crashed by -287bps to 0.36% in 2022, then tumbled by -57bps to 0.57% in 2023, then fell by -6bps to 0.6% in 2024, then soared by 40bps to 0.36% in 2025.
  • Its Return on Capital Employed was 0.36% in Q3 2025, compared to 0.4% in Q2 2025 and 0.42% in Q1 2025.